Hepatocellular carcinoma in 2014: Current situation and future prospects

Diagnostic and Interventional Imaging

Volumn 95, Issue 7-8, 2014, Pages 705-708

  Trinchet, J C ^a,b,c  

^a HÔPITAL JEAN VERDIER   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c Université Paris 13   (France)

Author keywords

Carcinoma; Cirrhosis; Liver; Screening; Tumor

Indexed keywords

AFLATOXIN B1; ALCOHOL; ALPHA FETOPROTEIN;

ALCOHOL CONSUMPTION; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; ASIAN; AUTOIMMUNE HEPATITIS; CANCER INHIBITION; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER SCREENING; CANCER SURVIVAL; CHEMOEMBOLIZATION; DISEASE SEVERITY; EPIDEMIOLOGY; FRANCE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONALCOHOLIC FATTY LIVER; PRIMARY BILIARY CIRRHOSIS; RADIOFREQUENCY ABLATION; SEX DIFFERENCE; CARCINOMA, HEPATOCELLULAR; FORECASTING; LIVER NEOPLASMS;

CARCINOMA, HEPATOCELLULAR; FORECASTING; HUMANS; LIVER NEOPLASMS;

EID: 84906935994     PISSN: None     EISSN: 22115684     Source Type: Journal    
DOI: 10.1016/j.diii.2014.04.005     Document Type: Short Survey

References (19)

1. Trinchet JC. Hepatocellular carcinoma: increasing inci-dence and optimized management. Gastroenterol Clin Biol2009;33:830-9.
2. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, et al.Decreased incidence of hepatocellular carcinoma in hepati-tis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst2009;101:1348-55.
3. Rosa I, Denis J, Renard P, Lesgourgues B, Dobrin AS, Becker C,et al. A French multicentric longitudinal descriptive study ofhepatocellular carcinoma management (The Changh Cohort):preliminary results. J Hepatol 2010;52:S231-2.
4. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellularcarcinoma in cirrhosis: incidence and risk factors. Gastroen-terology 2004;127:S35-50.
5. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF,Zein NN. The incidence and risk factors of hepatocellular carci-noma in patients with nonalcoholic steatohepatitis. Hepatology2010;51:1972-8.
6. Bruix J, Sherman M. Management of hepatocellular carcinoma:an update. Hepatology 2011;53:1020-2.
7. Trinchet JC, Chaffaut C, Bourcier V, Degos F, Henrion J,Fontaine H, et al. Ultrasonographic surveillance of hepatocel-lular carcinoma in cirrhosis: a randomized trial comparing 3-and 6-month periodicities. Hepatology 2011;54:1987-97.
8. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial ofscreening for hepatocellular carcinoma. J Cancer Res ClinOncol 2004;130:417-22.
9. Chan AC, Poon RT, Ng KK, Lo CM, Fan ST, Wong J. Chang-ing paradigm in the management of hepatocellular carcinomaimproves the survival benefit of early detection by screening.Ann Surg 2008;247:666-73.
10. Singal AG, Yopp AC, Gupta S, Skinner CS, Halm EA, Okolo E,et al. Failure rates in the hepatocellular carcinoma surveillanceprocess. Cancer Prev Res (Phila) 2012;5:1124-30.
11. Lencioni R, Crocetti L. Local-regional treatment of hepatocel-lular carcinoma. Radiology 2012;262:43-58.
12. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet2012;379:1245-55.
13. Seror O, N'Kontchou G, Ibraheem M, Ajavon Y, Barrucand C,Ganne N, et al. Large (≥ 5.0-cm) HCCs: multipolar RF ablationwith three internally cooled bipolar electrodes-initial experi-ence in 26 patients. Radiology 2008;248:288-96.
14. Salem R, Lewandowski RJ. Chemoembolization and radioem-bolization for hepatocellular carcinoma. Clin GastroenterolHepatol 2013;11:604-11.
15. Morgan RL, Baack B, Smith BD, Yartel A, Pitasi M, Falck-Ytter Y.Eradication of hepatitis C virus infection and the developmentof hepatocellular carcinoma: a meta-analysis of observationalstudies. Ann Intern Med 2013;158:329-37.
16. Kumada T, Toyoda H, Tada T, Kiriyama S, Tanikawa M, HisanagaY, et al. Effect of nucleos(t)ide analogue therapy on hepatocar-cinogenesis in chronic hepatitis B patients: a propensity scoreanalysis. J Hepatol 2013;58:427-33.
17. Zhang H, Gao C, Fang L, Zhao HC, Yao SK. Metforminand reduced risk of hepatocellular carcinoma in diabeticpatients: a meta-analysis. Scand J Gastroenterol 2013;48:78-87.
18. Singh S, Singh PP. Metformin and risk of hepatocellu-lar carcinoma: are statins the missing link? Gut 2013;62:951-2.
19. Trinchet JC. Surveillance for hepatocellular carcinoma in cir-rhotic patients: from official recommendations to the real life.J Hepatol 2011;54:1310-1.